Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Dutasteride in Men with Androgenetic Alopecia
NCT05599243Phase 2Completed
- Start
- Sep 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride in androgenetic alopecia (AGA). Started Sep 2022; status: completed.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05599243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05599243.